Astrazeneca Plc ADR (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
Sales | 7,898,000 | 8,178,000 | 8,576,000 | 8,945,000 | 8,200,000 |
Cost of Goods | 1,524,000 | 1,452,000 | 1,654,000 | 1,665,000 | 1,263,000 |
Gross Profit | 6,374,000 | 6,726,000 | 6,922,000 | 7,280,000 | 6,937,000 |
Operating Expenses | 3,968,000 | 3,858,000 | 3,531,000 | 4,317,000 | 3,792,000 |
Operating Income | 2,406,000 | 2,868,000 | 3,391,000 | 2,963,000 | 3,145,000 |
Other Income | -148,000 | 49,000 | 128,000 | -799,000 | -113,000 |
Pre-tax Income | 2,258,000 | 2,917,000 | 3,519,000 | 2,164,000 | 3,032,000 |
Income Tax | 704,000 | 801,000 | 740,000 | 602,000 | 911,000 |
Net Income Continuous | 1,554,000 | 2,116,000 | 2,777,000 | 1,562,000 | 2,115,000 |
Net Income | $1,554,000 | $2,116,000 | $2,777,000 | $1,562,000 | $2,115,000 |
EPS Basic Total Ops | 0.54 | 0.73 | 0.96 | 0.54 | 0.73 |
EPS Basic Continuous Ops | 0.54 | 0.73 | 0.96 | 0.54 | 0.73 |
EPS Diluted Total Ops | 0.54 | 0.73 | 0.96 | 0.54 | 0.73 |
EPS Diluted Continuous Ops | 0.54 | 0.73 | 0.96 | 0.54 | 0.73 |
EBITDA(a) | $3,008,000 | $3,299,000 | $3,792,000 | $3,738,000 | $3,608,000 |